LifeCodexx AG, headquartered in Germany, is a pioneering company in the field of molecular diagnostics, specialising in non-invasive prenatal testing (NIPT). Founded in 2012, LifeCodexx has established itself as a leader in genetic testing, offering innovative solutions that empower expectant parents with critical information about their unborn child's health. The company’s flagship product, the LifeCodexx NIPT, stands out for its accuracy and reliability, utilising advanced genomic technologies to analyse cell-free DNA from maternal blood. With a commitment to quality and precision, LifeCodexx AG has achieved significant milestones, including regulatory approvals and partnerships that enhance its market presence across Europe and beyond. Recognised for its contributions to prenatal care, LifeCodexx AG continues to shape the future of genetic testing, ensuring that families receive the best possible insights into their health and wellbeing.
We don't have data for LifeCodexx AG, but we can show you information about their parent organization instead.
View parent company